Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL38434 (Brequinar) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
dihydrofolate reductase/Dihydrofolate reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL202] [GtoPdb: 2603] [UniProtKB: P00374] | ||||||||
ChEMBL | Inhibition of recombinant human N-terminal truncated GST-tagged DHFR (31 to 395 residues) expressed in Escherichia coli BL21(DE3) pyrD using DHO as substrate preincubated for 5 mins followed by substrate addition measured for 5 mins by DCIP oxidation based CoQ10 enzyme coupled assay | B | 8.74 | pIC50 | 1.8 | nM | IC50 | Eur J Med Chem (2017) 129: 287-302 [PMID:28235702] |
dihydroorotate dehydrogenase (quinone)/Dihydroorotate dehydrogenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1966] [GtoPdb: 2604] [UniProtKB: Q02127] | ||||||||
GtoPdb | - | - | 7 | pKi | 100 | nM | Ki | Invest New Drugs (1987) 5: 235-44 [PMID:2822596] |
ChEMBL | Inhibition measurement of orotate formation from radiolabeled dihydroorotate, using partially purified DHODase isolated from human liver. | B | 7.92 | pKi | 12 | nM | Ki | Bioorg Med Chem Lett (1995) 5: 1549-1554 |
ChEMBL | Inhibition of His-tagged human DHODH assessed as reduction of DCIP by spectrophotometry | B | 7.4 | pIC50 | 39.81 | nM | IC50 | J Med Chem (2015) 58: 860-877 [PMID:25558988] |
ChEMBL | Inhibition of human DHODH | B | 7.43 | pIC50 | 37 | nM | IC50 | Eur J Med Chem (2019) 183: 111681-111681 [PMID:31557612] |
ChEMBL | Inhibition of human recombinant full length C-terminal MYC/DDk-tagged DHODH using decylubiquinone as substrate measured for 1 hr by DCIP absorbance assay | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2021) 64: 4762-4786 [PMID:33835811] |
ChEMBL | Inhibition of DHODH (unknown origin) using L-DHO, DUQ, DCIP as substrate preincubated for 30 mins followed by substrate addition measured after 20 mins by multilabel plate reader analysis | B | 7.92 | pIC50 | 12 | nM | IC50 | Bioorg Med Chem (2015) 23: 4669-4680 [PMID:26088338] |
ChEMBL | Inhibition of human DHODH | B | 7.92 | pIC50 | 12 | nM | IC50 | ACS Med Chem Lett (2013) 4: 517-521 [PMID:23930152] |
ChEMBL | Inhibition of recombinant N-terminal His-tagged human DHODH (31 to 395 residues) expressed in Escherichia coli using L-DHO as substrate measured every 10 mins for 90 mins in presence of decylubiquinone by DCIP based colorimetric assay | B | 7.92 | pIC50 | 12 | nM | IC50 | Bioorg Med Chem (2020) 28: 115739-115739 [PMID:33007554] |
ChEMBL | Inhibition of human purified recombinant DHODH | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2013) 56: 3148-3167 [PMID:23452331] |
ChEMBL | Inhibition of human recombinant DHODH expressed in baculovirus infected insect cells using dihydroorotate as substrate in presence of quinone by dichlorophenol-indophenol dye based assay | B | 8 | pIC50 | 10 | nM | IC50 | ACS Med Chem Lett (2016) 7: 1112-1117 [PMID:27994748] |
ChEMBL | Inhibition of human recombinant DHODH | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2015) 58: 5579-5598 [PMID:26079043] |
ChEMBL | Inhibition of human DHODH using dihydroorotate substrate by DCIP assay | B | 8.08 | pIC50 | 8.4 | nM | IC50 | Medchemcomm (2017) 8: 1297-1302 [PMID:30108840] |
ChEMBL | Inhibitory activity against recombinant human DHODH | B | 8.1 | pIC50 | 8 | nM | IC50 | Bioorg Med Chem Lett (2006) 16: 267-270 [PMID:16246558] |
ChEMBL | Inhibition of N-terminally truncated human DHODH (Met30 to Arg396 residues) expressed in Escherichia coli BL21 (DE3) using dihydroorotate as substrate preincubated for 5 mins followed by substrate addition measured every 30 secs for 6 mins by DCIP-based spectrophotometric assay | B | 8.13 | pIC50 | 7.4 | nM | IC50 | Medchemcomm (2016) 7: 853-858 |
ChEMBL | Inhibition of DHODH (unknown origin) expressed in Escherichia coli Rosetta2(DE3) assessed as reduction of DCIP using dihydroorotate as substrate preincubated for 30 mins followed by substrate addition in presence of CoQ10 measured after 1 hr | B | 8.14 | pIC50 | 7.3 | nM | IC50 | J Med Chem (2018) 61: 5162-5186 [PMID:29727569] |
ChEMBL | Inhibition of human DHODH | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (2013) 56: 3148-3167 [PMID:23452331] |
ChEMBL | Inhibition of human DHODH using dihydroorotate as substrate and CoQ10 as co-substrate preincubated for 30 mins followed by substrate addition by DCIP coupled microplate reader assay | B | 8.28 | pIC50 | 5.2 | nM | IC50 | J Med Chem (2020) 63: 7633-7652 [PMID:32496056] |
ChEMBL | Inhibition of recombinant N-terminal His-tagged human DHODH (31 to 395 residues) expressed in Escherichia coli using DL-dihydroorotic acid as substrate and Q0 as coenzyme by DCIP based assay | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2021) 64: 13918-13932 [PMID:34516133] |
ChEMBL | Inhibition of human recombinant DHODH | B | 8.4 | pIC50 | 4 | nM | IC50 | ACS Med Chem Lett (2016) 7: 1112-1117 [PMID:27994748] |
ChEMBL | Inhibition of recombinant human DHODH by using blue indicator dye DCIP | B | 8.52 | pIC50 | 3 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 1981-1984 [PMID:20153645] |
ChEMBL | Inhibition of recombinant human N-terminal GST-fusion tagged DHODH expressed in Escherichia coli BL21 (DE3) using dihydroorotate as substrate at 50 uM preincubated for 5 mins followed by substrate addition measured after 5 mins by DCIP assay | B | 8.74 | pIC50 | 1.8 | nM | IC50 | J Med Chem (2022) 65: 12701-12724 [PMID:36162075] |
ChEMBL | Inhibition of recombinant N-terminal GST-tagged human DHODH (31 to 395 residues) expressed in Escherichia coli BL21(DE3) assessed as inhibition of DCIP reduction using dihydroorotate as substrate preincubated for 5 mins followed by substrate addition measured after 5 mins | B | 8.74 | pIC50 | 1.8 | nM | IC50 | J Med Chem (2018) 61: 6034-6055 [PMID:29939742] |
ChEMBL | Inhibition of human recombinant N-terminal GST-tagged DHODH expressed in Escherichia coli BL21(DE3) using dihydroorotate substrate preincubated for 5 mins followed by substrate addition by DCIP assay | B | 8.74 | pIC50 | 1.8 | nM | IC50 | J Med Chem (2021) 64: 5404-5428 [PMID:33844533] |
ChEMBL | Inhibition of human DHODH | B | 9.32 | pIC50 | 0.48 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127589-127589 [PMID:33007394] |
dihydroorotate dehydrogenase (quinone)/Dihydroorotate dehydrogenase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2383] [GtoPdb: 2604] [UniProtKB: Q63707] | ||||||||
ChEMBL | Inhibition of rat purified recombinant DHODH | B | 6.44 | pIC50 | 367 | nM | IC50 | J Med Chem (2013) 56: 3148-3167 [PMID:23452331] |
ChEMBL | Inhibition of rat recombinant His-tagged truncated DHODH expressed in Escherichia coli using dihydroorotate as substrate by chromogen reduction assay | B | 6.9 | pIC50 | 127 | nM | IC50 | J Med Chem (2013) 56: 3148-3167 [PMID:23452331] |
ChEMBL | Inhibition of dihydroorotate dehydrogenase in Wistar rat liver mitochondrial/microsomal membranes measured for 5 mins by 2,6-dichlorophenolindophenol reduction-based spectrophotometry | B | 7.48 | pIC50 | 33 | nM | IC50 | Eur J Med Chem (2012) 49: 102-109 [PMID:22245049] |
Dihydroorotate dehydrogenase (quinone), mitochondrial in Schistosoma mansoni (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523950] [UniProtKB: G4VFD7] | ||||||||
ChEMBL | Inhibition of Schistosoma mansoni DHODH using DHO as substrate measured at 4 secs interval for 60 secs by DCIP reduction based indirect assay | B | 4.7 | pIC50 | 20000 | nM | IC50 | Eur J Med Chem (2019) 167: 357-366 [PMID:30776695] |
ChEMBL | Inhibition of Schistosoma mansoni DHODH | B | 4.7 | pIC50 | 20000 | nM | IC50 | Eur J Med Chem (2019) 183: 111681-111681 [PMID:31557612] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]